Chronic corticosterone shifts effort-related choice behavior in male mice.
Chronic stress
Corticosterone
Depression
Effort-related choice behavior
Reward
Journal
Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
19
06
2019
accepted:
02
04
2020
pubmed:
19
4
2020
medline:
21
10
2020
entrez:
19
4
2020
Statut:
ppublish
Résumé
Effort-related choice tasks are used to study aspects of motivation in both rodents and humans (Der-Avakian and Pizzagalli Biol Psychiatry 83(11):932-939, 2018). Various dopaminergic manipulations and antidepressant treatments can shift responding to these tasks (Randall et al. Int J Neuropsychopharmacol 18(2), 2014; Yohn et al. Psychopharmacology 232(7):1313-1323, 2015). However, while chronic stress can precipitate mood disorders in humans, there is relatively little known about whether chronic stress elicits maladaptive behaviors in rodent effort-related choice tasks. Chronic corticosterone (CORT) elicits an increase in negative maladaptive behaviors in male mice (David et al. Neuron 62(4):479-493, 2009; Gourley et al. Biol Psychiatry 64(10):884-890, 2008; Olausson et al. Psychopharmacology 225(3):569-577, 2013). We hypothesized that chronic CORT administration to male mice would reduce motivation for a higher effort, higher reward option, and shift responding to a less effortful, but a lesser reward. Adult male C57BL/6J mice were administered either vehicle (n = 10) or CORT (n = 10) (~ 9.5 mg/kg/day) in their drinking water for 4 weeks, and then throughout all behavioral experiments (15 weeks total), and were tested in a Y-Maze barrier task and a fixed ratio concurrent (FR/chow) choice task. Chronic CORT reduced Y-maze HR arm choice when more effort was required to obtain the 4 food pellets (15-cm barrier in the high-reward (HR) arm, p < 0.001; 20-cm barrier in HR arm, p < 0.001) and shifted choice to the low reward (LR) arm where only 2 pellets were available. Chronic CORT also reduced lever pressing for food pellets in FR30/chow sessions of the concurrent choice task (p = 0.009), without impacting lab chow consumed. Chronic stress induces maladaptive shifts in effort-related choice behavior in the Y-maze barrier task in male mice. Furthermore, males subjected to chronic CORT administration show reduced lever pressing in FR30/chow sessions where lab chow is concurrently available. These data demonstrate that chronic corticosterone reduces motivation to work for and obtain a highly rewarding reinforcer when a lesser reinforcer is concurrently available.
Identifiants
pubmed: 32303779
doi: 10.1007/s00213-020-05521-z
pii: 10.1007/s00213-020-05521-z
pmc: PMC7308188
mid: NIHMS1585805
doi:
Substances chimiques
Corticosterone
W980KJ009P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2103-2110Subventions
Organisme : NIMH NIH HHS
ID : R01 MH112861
Pays : United States
Références
Neuropsychopharmacology. 2016 Feb;41(3):686-94
pubmed: 26105139
Neuron. 2009 May 28;62(4):479-93
pubmed: 19477151
Comp Med. 2012 Oct;62(5):348-60
pubmed: 23114038
Int J Neuropsychopharmacol. 2014 Oct 31;18(2):
pubmed: 25575584
Brain. 2016 May;139(Pt 5):1325-47
pubmed: 27189581
Biol Psychiatry. 2008 May 1;63(9):847-51
pubmed: 18005940
Psychopharmacology (Berl). 2013 Feb;225(3):569-77
pubmed: 22983097
PLoS One. 2012;7(10):e47934
pubmed: 23110135
Psychopharmacology (Berl). 2014 Feb;231(4):727-36
pubmed: 24136220
Behav Brain Res. 1994 Dec 15;65(2):221-9
pubmed: 7718155
Neuropharmacology. 2011 Sep;61(3):408-13
pubmed: 21356220
Biol Psychiatry. 2008 Nov 15;64(10):884-90
pubmed: 18675955
Biol Psychiatry. 2018 Jun 1;83(11):932-939
pubmed: 29615189
Acta Physiol (Oxf). 2018 Jun;223(2):e13066
pubmed: 29575542
Psychopharmacology (Berl). 2015 Apr;232(7):1313-23
pubmed: 25323625
Psychoneuroendocrinology. 2010 Oct;35(9):1275-86
pubmed: 20447770
Compr Psychiatry. 1997 Sep-Oct;38(5):260-3
pubmed: 9298317
Psychoneuroendocrinology. 2017 Dec;86:218-224
pubmed: 29020649
Psychopharmacology (Berl). 1996 May;125(2):105-12
pubmed: 8783383
PLoS One. 2009 Aug 12;4(8):e6598
pubmed: 19672310
Steroids. 2016 Dec;116:76-82
pubmed: 27815034
Neuropsychopharmacology. 2006 Jul;31(7):1362-70
pubmed: 16319913
Curr Top Behav Neurosci. 2016;28:231-62
pubmed: 26873017
Neuropharmacology. 2012 Apr;62(5-6):2068-77
pubmed: 22261384
Neuropsychopharmacology. 2016 Jul;41(8):2147-59
pubmed: 26830960
Psychoneuroendocrinology. 2013 Jun;38(6):927-40
pubmed: 23122890
Pharmacol Rev. 2018 Oct;70(4):747-762
pubmed: 30209181
Neuropsychopharmacology. 2012 Sep;37(10):2194-209
pubmed: 22569506
J Pharmacol Exp Ther. 2003 Apr;305(1):1-8
pubmed: 12649346